Cox & Kings EBITDA margin
Quel est le EBITDA margin de Cox & Kings?
Le EBITDA margin de Cox & Kings Limited est -11,428.57%
Quelle est la définition de EBITDA margin?
EBITDA margin is a profitability ratio that measures how much EBITDA the company generates as a percentage of revenue.
ttm (trailing twelve months)
EBITDA margin measures how much of EBITDA is generated as a percentage of sales. It measures the company’s operating profit as a percentage of its revenue and is calculated as EBITDA (earnings before interest, taxes, depreciation, and amortization) divided by total revenue.
EBITDA margin also helps with judging the effectiveness of cost-cutting processes at the company. The higher the company’s EBITDA margin, the lower operating expenses are in respect to revenue. As a result, a higher EBITDA margin is considered more favorable. Smaller companies can have higher EBITDA margins since they are able to operate more efficiently and maximize their profitability.
EBITDA excludes interest on debt, taxes, and capital expenditures, the margin does not provide a perfectly clear estimate of the business’s cash flow generation. Furthermore, EBITDA margin is not recognized as a GAAP (generally accepted accounting principles) metric.
EBITDA margin des entreprises dans Consumer Discretionary secteur sur NSE par rapport à Cox & Kings
Que fait Cox & Kings?
Cox & Kings Limited provides tours and travel services worldwide. It primarily offers destination management, outbound tourism, business travel, incentive and conference solutions, domestic holidays, and trade fairs services. The company was formerly known as Cox and Kings (India) Limited and changed its name to Cox & Kings Limited in July 2010. Cox & Kings Limited was founded in 1758 and is based in Mumbai, India.
Entreprises avec ebitda margin similaire à Cox & Kings
- Kaleido Biosciences Inc a EBITDA margin de -11,658.74%
- Predictiv AI a EBITDA margin de -11,506.76%
- Internet of Things a EBITDA margin de -11,506.76%
- Perk Labs a EBITDA margin de -11,490.40%
- Albion Resources Ltd a EBITDA margin de -11,464.10%
- Calyxt Inc a EBITDA margin de -11,433.53%
- Cox & Kings a EBITDA margin de -11,428.57%
- Clene Nanomedicine a EBITDA margin de -11,425.57%
- Talga Resources a EBITDA margin de -11,365.21%
- China New Economy Fund a EBITDA margin de -11,353.08%
- genedrive plc a EBITDA margin de -11,330.61%
- Centaurus Metals a EBITDA margin de -11,291.14%
- Acasti Pharma a EBITDA margin de -11,186.96%